-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Maintains Buy on Arrowhead Pharma, Lowers Price Target to $96

Benzinga·11/13/2026 12:52:02
Stifel analyst James Condulis maintains Arrowhead Pharma (NASDAQ:ARWR) with a Buy and lowers the price target from $104 to $96.